Skip to content

    Research Use Only

    This site is an independent educational resource for research compounds. We do not sell, distribute, or endorse human consumption of any compound. By entering, you confirm you are 21 years of age or older and agree to our Terms & Privacy Policy.

    🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide
    Adera logo

    Adera

    Pharmaceutical-grade nasal sprays, sublingual pouches & nootropic capsules — third-party NMR + HPLC tested

    Visit Adera

    Save with code BODYHACKGUIDE at checkout

    Founded

    2023

    Payments

    Credit Card, Crypto

    About Adera

    Adera formulates nootropic and research-compound stacks around the pharmacology most supplement brands won't touch — Sabroxy, Theacrine, Dynamine, Kavain, Phenibut, Selank, and BDNF-mimetic peptides — and ships them in delivery formats the kinetics actually call for. Sublingual pouches for fast-onset xanthines. Nasal sprays for peptides that don't survive first-pass metabolism. Capsule stacks dosed at the upper end of what the preclinical literature references, not the "fairy dust" 20 mg token loadings you see on retail shelves. Every batch is tested by a third-party lab using NMR (structural confirmation) and HPLC (quantitative purity). Certificates of analysis are available on request. No proprietary blends. No therapeutic claims the evidence doesn't support. Research-use labeling on everything. Pricing is set around cost-of-goods rather than brand markup — the team treats this more like a compounding lab than a consumer supplement company.

    Mission

    Deliver pharmaceutical-grade research compounds in formats the pharmacokinetics actually justify. Third-party NMR + HPLC test every batch. Publish the COA on request. Label every product research-use. Dose at the upper end of what the literature references, not the lower end of what makes margin sense. Refuse proprietary blends, therapeutic claims, and underdosed showpiece ingredients.

    Founder's Story

    Adera came out of frustration. The founders were researchers running their own stacks, and they kept hitting the same wall: the supplement market sold them underdosed ingredients in the wrong delivery format, while the peptide/research chemical market sold them questionable purity and zero third-party testing. So they started formulating for themselves. Sublingual pouches because Theacrine hits in 15 minutes that way. Nasal sprays because Selank and BDNF mimetics don't tolerate oral administration. Capsules at 600 mg Sabroxy because that's what the MAO-B inhibition data references, not 50 mg because "that's what everyone else does." Friends asked for the same blends. Then colleagues. Then strangers on research forums. Adera opened in 2023 to ship what the founders were already making — with the same third-party testing they'd demand for their own use, the same mechanistic honesty in the labeling, and the same respect for research-use framing. The catalog today spans focus (BLITZED, AMP Pouches), sleep (Hypnos), social anxiety (INHBT), and peptide delivery (Selank Spray, BDNF Spray). Everything ships from the US with a 48-hour fulfillment target.

    Featured

    Flagship Formulas

    Tap a card to explore. Ships direct from Adera.

    BLITZED
    In Stock

    Focus Formula

    BLITZED

    Ultimate focus stack for peak mental performance. Clean drive, zero crash — engineered for the grind.

    Focus
    96%
    Energy
    92%
    95% Charge

    Third-Party Testing

    Every product page for Adera includes a Certificate of Analysis (COA) from an independent lab (Third-party certified lab (NMR + HPLC)). COAs confirm identity, purity, and endotoxin levels for research-grade compounds.

    Verified

    0

    Pending

    0

    Average Purity

    Research Focus

    Sabroxy (Oroxylum indicum / baicalein): MAO-B inhibition research

    Sabroxy is a standardized extract of Oroxylum indicum bark, with baicalein as the primary bioactive flavonoid. The mechanistic interest centers on preferential MAO-B inhibition: in vitro and rodent data suggest baicalein inhibits MAO-B at concentrations that leave MAO-A largely intact ([Chan et al., 2017](https://pubmed.ncbi.nlm.nih.gov/28441433/)). Because MAO-B is the primary catabolic enzyme for dopamine in the striatum, selective MAO-B inhibition can preserve endogenous dopamine signaling without the pressor risks of MAO-A inhibition. Baicalein also shows anti-inflammatory and neuroprotective activity in several neurodegeneration models, with evidence for GSK-3β modulation and anti-apoptotic signaling. BLITZED uses 600 mg standardized extract per serving; AMP Pouches use 40 mg sublingual. The capsule dose sits in the upper range of what's referenced in the MAO-B inhibition preclinical literature; the pouch dose is lower because sublingual bioavailability is meaningfully higher than oral (first-pass metabolism bypassed). **Research-use only.** Human data on Sabroxy specifically is sparse — most of the mechanistic evidence comes from in vitro and rodent studies. Do not combine with MAOI medications.

    Theacrine and methylliberine (Dynamine): tolerance profile vs caffeine

    Theacrine (1,3,7,9-tetramethyluric acid) shares adenosine-receptor pharmacology with caffeine but has a distinct tolerance curve. In a small human trial, 8 weeks of daily 300 mg theacrine showed no meaningful tolerance development on subjective measures of energy and focus ([Taylor et al., 2016](https://pubmed.ncbi.nlm.nih.gov/26690174/)). Acute studies suggest overlapping but non-identical receptor profiles ([Kuhman et al., 2015](https://pubmed.ncbi.nlm.nih.gov/26068605/)). Methylliberine (Dynamine) is a related purine alkaloid. Single-dose studies in humans show acute cognitive and mood effects with a fast onset (15–30 min sublingually) and relatively short duration (~2 hours) ([VanDusseldorp et al., 2020](https://pubmed.ncbi.nlm.nih.gov/32175020/)). Adera uses theacrine in BLITZED (240 mg capsule) and AMP Pouches (50 mg sublingual). Methylliberine appears only in AMP Pouches (40 mg sublingual), where the faster kinetics match the sublingual format. **Research-use framing:** both compounds are GRAS in the US for supplement use. Research into long-term daily use beyond 8 weeks is limited.

    L-Theanine: glutamate modulation and alpha-wave evidence

    L-Theanine is the ethylamine derivative of glutamic acid found in Camellia sinensis (green tea). It crosses the blood-brain barrier and shows glutamate-receptor modulation (NMDA/AMPA antagonism at pharmacologic doses) along with increased alpha-wave EEG activity at relaxation-dose ranges ([Nobre et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18296328/); [Kimura et al., 2007](https://pubmed.ncbi.nlm.nih.gov/16930802/)). Co-administration with caffeine or caffeine-class xanthines (theacrine, methylliberine) attenuates stimulant-induced increases in heart rate and subjective jitter while preserving cognitive-performance benefits, which is why nearly every premium focus stack pairs the two ([Owen et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18641209/)). Adera doses L-Theanine at 240 mg in BLITZED (capsule) and 50 mg in AMP Pouches (sublingual). The sublingual dose is proportionally higher when accounting for delivery — 50 mg sublingual is roughly bioequivalent to 100–150 mg oral.

    Kavain (isolated): GABA-A positive allosteric modulation

    Kavain is one of six major kavalactones in Piper methysticum. It acts as a positive allosteric modulator of GABA-A receptors and also shows voltage-gated sodium-channel modulation in vitro ([Singh & Singh, 2002](https://pubmed.ncbi.nlm.nih.gov/11830761/); [Grunze et al., 2001](https://pubmed.ncbi.nlm.nih.gov/11356024/)). The key distinction from traditional kava: Hypnos uses **isolated kavain**, not a full-spectrum aqueous or ethanolic kava root extract. The kava hepatotoxicity signal in the early 2000s was predominantly associated with ethanolic or acetonic extracts that contained pipermethystine and certain flavokavins not present in purified kavain preparations ([Teschke, 2010](https://pubmed.ncbi.nlm.nih.gov/20353341/)). That said, the purified-kavain safety profile is not fully established — absence of published hepatotoxicity signals is not proof of safety, and the prudent protocol limits frequency and avoids co-exposure with alcohol and hepatotoxic medications. Hypnos doses kavain at 400 mg per serving alongside oleamide, scutellaria baicalensis, apigenin, tetrahydromagnolol, and low-dose melatonin. The stack is designed for sleep onset and early-night maintenance.

    Phenibut (INHBT): GABA-B agonism and tolerance pharmacology

    Phenibut is β-phenyl-γ-aminobutyric acid — a GABA analog with a phenyl group that allows blood-brain barrier penetration. Its primary pharmacology is GABA-B receptor agonism, with weaker activity at GABA-A and voltage-gated calcium channels at higher doses ([Lapin, 2001](https://pubmed.ncbi.nlm.nih.gov/11830761/)). Tolerance develops rapidly at the GABA-B site with repeated exposure — a pattern well-characterized in clinical experience with baclofen (a more selective GABA-B agonist used for spasticity). Daily or near-daily phenibut use produces tolerance within 1–2 weeks and can produce a severe withdrawal syndrome ([Samokhvalov et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23410822/); [Magsalin & Khan, 2010](https://pubmed.ncbi.nlm.nih.gov/20456842/)) with clinical features overlapping alcohol and benzodiazepine withdrawal (anxiety, autonomic dysregulation, insomnia, seizure risk in severe cases). INHBT's cycling protocol (max 1 capsule per week, no consecutive days, 7-day washout minimum) is designed around this pharmacology. Users who exceed it run into the tolerance-withdrawal cycle that accounts for most negative phenibut case reports. Do not combine with alcohol, benzodiazepines, baclofen, GHB analogs, or other significant GABAergic compounds. Research use only. Restricted jurisdictions listed on product page.

    Selank: tuftsin-derivative peptide and BDNF downstream signaling

    Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a synthetic heptapeptide derived from tuftsin, developed at the Institute of Molecular Genetics (Moscow). The compound has been studied primarily in Russian clinical research for generalized anxiety and mild cognitive dysfunction. Mechanistic work suggests Selank up-regulates BDNF and NGF expression in rodent hippocampus, modulates GABAergic signaling downstream of GABA-A receptor changes in expression, and produces anxiolytic effects comparable to benzodiazepines without the sedation or dependency liability ([Kolomin et al., 2013](https://pubmed.ncbi.nlm.nih.gov/23829768/); [Zozulia et al., 2008](https://pubmed.ncbi.nlm.nih.gov/18432189/)). The proposed mechanism overlaps with other neuropeptide anxiolytics in its apparent non-sedating profile. Intranasal delivery is the preferred administration route because oral bioavailability is near zero — the peptide bonds don't survive gastric hydrolysis. See [Selank on BodyHackGuide](/compound/selank) for the full mechanism brief and clinical research summary. **Research-use framing:** Selank is not FDA-approved for any indication and is not a scheduled substance in the US. The Russian clinical research has not been replicated in Western trials.

    BDNF-mimetic small molecules: TrkB activation and neuroplasticity

    The BDNF Spray formulates a small-molecule TrkB agonist rather than BDNF protein itself. BDNF (brain-derived neurotrophic factor) is a ~14 kDa protein that signals through the TrkB receptor to drive synaptic plasticity, neuronal survival, and long-term potentiation. BDNF protein itself is not clinically usable as a therapeutic — it doesn't cross the blood-brain barrier efficiently and doesn't survive intranasal delivery as a stable formulation. Small-molecule TrkB agonists (including 7,8-dihydroxyflavone and related compounds) have been developed as BDNF mimetics — they activate the same downstream signaling cascade without requiring delivery of the full protein ([Jang et al., 2010](https://pubmed.ncbi.nlm.nih.gov/20631322/); [Liu et al., 2014](https://pubmed.ncbi.nlm.nih.gov/24709640/)). Intranasal delivery bypasses first-pass metabolism and allows meaningful CNS concentrations at practical dose volumes. Onset is not acutely obvious the way a stimulant is — BDNF-downstream effects are structural (long-term potentiation, dendritic remodeling) rather than acute receptor effects, so research typically frames benefit over weeks rather than hours. **Research-use only.** No FDA approval. Mechanism research is robust; human clinical evidence for specific cognitive or mood endpoints is still emerging.

    Hypnos support ingredients: apigenin, tetrahydromagnolol, scutellaria

    Beyond kavain, Hypnos stacks three support ingredients with complementary GABAergic / sleep-consolidating mechanisms: **Apigenin** is a flavonoid found in chamomile, parsley, and celery that binds benzodiazepine-site GABA-A receptors at moderate affinity and shows sedative effects in rodent models ([Salgueiro et al., 1997](https://pubmed.ncbi.nlm.nih.gov/9259847/); [Avallone et al., 2000](https://pubmed.ncbi.nlm.nih.gov/10692657/)). Hypnos uses 100 mg — at the higher end of what's practical in an oral supplement given apigenin's limited bioavailability. **Tetrahydromagnolol** (THM) is a reduced derivative of magnolol from Magnolia officinalis bark. It shows GABA-A positive allosteric modulation with a profile distinct from benzodiazepines and appears to have anti-anxiety and sedative activity in preclinical models ([Alexeev et al., 2012](https://pubmed.ncbi.nlm.nih.gov/22425748/)). 50 mg in Hypnos. **Scutellaria baicalensis** extract standardized to baicalin — baicalin and its aglycone baicalein are GABA-A positive modulators and show anxiolytic/sedative effects in rodent studies ([Liao et al., 2003](https://pubmed.ncbi.nlm.nih.gov/12665324/)). 200 mg in Hypnos. The combination targets multiple GABA-A binding sites at moderate doses each, rather than maximizing any single one.

    Mucuna pruriens: standardized L-DOPA pharmacokinetics vs pharmaceutical levodopa

    Mucuna pruriens seeds contain levodopa (L-3,4-dihydroxyphenylalanine, L-DOPA) as the primary bioactive compound, standardized in supplements to a fixed percentage (BLITZED uses 98% L-DOPA standardization at 120 mg). L-DOPA crosses the blood-brain barrier where it's decarboxylated to dopamine in dopaminergic neurons, providing acute dopaminergic support. Interestingly, a crossover trial in Parkinson's patients found that Mucuna extract at equivalent L-DOPA doses produced a faster onset, higher peak plasma levels, and longer duration of effect vs pharmaceutical levodopa/carbidopa ([Katzenschlager et al., 2004](https://pubmed.ncbi.nlm.nih.gov/15377700/)) — suggesting the plant matrix contains additional compounds (possibly peripheral decarboxylase modulators, or secondary alkaloids) that favorably modify L-DOPA kinetics. For nootropic use in non-Parkinson's populations, the 120 mg L-DOPA equivalent in BLITZED is substantially below pharmaceutical Parkinson's dosing (which runs 300-1200 mg/day) but sufficient to provide acute dopaminergic modulation alongside the other dopamine-relevant ingredients (DMHA releasing catecholamines, theacrine's dopaminergic effects, saffron's monoamine activity). **Research-use framing:** Mucuna is GRAS for supplement use. Do not combine with MAOI medications. Hypertensive risk is theoretical but low at this dose in healthy individuals.

    Huperzine A: reversible acetylcholinesterase inhibition

    Huperzine A is an alkaloid isolated from Huperzia serrata (Chinese club moss) that acts as a reversible, selective, blood-brain-barrier-penetrant acetylcholinesterase inhibitor. Mechanistically similar to pharmaceutical AChEIs (donepezil, rivastigmine) but with a distinct pharmacokinetic profile. Clinical research in mild cognitive impairment and Alzheimer's has shown cognitive benefit in some trials ([Xu et al., 1995](https://pubmed.ncbi.nlm.nih.gov/8701750/); [Rafii et al., 2011](https://pubmed.ncbi.nlm.nih.gov/21482934/)), though evidence quality varies and Western replication has been inconsistent. Mechanistic work extends beyond cholinergic modulation to include NMDA receptor antagonism and potential neuroprotective effects in oxidative stress models. INHBT uses 400 mcg — a moderate dose relative to the 100-800 mcg range used in clinical research. The cholinergic layer is included specifically to offset the phenibut-induced cognitive dulling some users report at higher doses; the rationale is mechanistic rather than synergistic. **Research-use framing:** Huperzine A is available as a dietary supplement in the US but regulated as a pharmaceutical in some other countries. Cholinergic side effects (GI upset, bradycardia, fasciculations) can occur at doses above 200 mcg in sensitive individuals — the INHBT dose splits the difference between "meaningful" and "side-effect-prone."

    Frequently Asked Questions

    What is the BLITZED dosing protocol?+
    BLITZED is designed as a once-daily morning capsule with research dosing anchored on Sabroxy 600 mg (Oroxylum indicum standardized to 35% baicalein). Start with 1 capsule taken with food between 7am and 10am — food matters here because several ingredients (Rhodiola, DMHA, Mucuna) have different kinetics on an empty vs full stomach. Ingredient loadings per serving: Sabroxy 600 mg, TeaCrine (theacrine) 240 mg, L-Theanine 240 mg, Rhodiola rosea (3% rosavins) 225 mg, Mucuna pruriens (98% L-Dopa) 120 mg, 2-aminoisoheptane (DMHA) 90 mg, saffron 28 mg, taurine (TAU) 25 mg, P5P (active B6) 10 mg. Onset is typically 45–90 minutes. Duration runs 5–7 hours with the DMHA/theacrine combo providing most of the front-end stimulation and the L-Theanine/L-Dopa/P5P combo smoothing the curve. Do not combine with additional caffeine on the same day until you've established tolerance — the theacrine + DMHA stack is already at upper-end stimulant territory. Cycling: 5 days on / 2 days off is the common framework to preserve sensitivity. The Rhodiola and L-Dopa precursors benefit from the break.
    How do AMP Pouches dose and what is the onset time?+
    AMP Pouches are sublingual. Place one pouch under your tongue or between your cheek and gum and let it sit for 15–20 minutes. Do not swallow the pouch. Do not chew. Absorption happens through the oral mucosa which bypasses first-pass hepatic metabolism, which is why the ingredient loadings look lower than BLITZED but the effect shows up faster. Per-pouch loading: Theacrine 50 mg, L-Theanine 50 mg, Dynamine (methylliberine) 40 mg, Sabroxy 40 mg, Taurine 25 mg, CDP-Choline 20 mg, Kanna 15 mg. Onset is typically 10–25 minutes. Duration runs 2.5–4 hours. The faster kinetics make AMP a better fit for situational focus (pre-meeting, pre-training, pre-social event) vs BLITZED's all-morning profile. Many users stack 1 AMP pouch with a BLITZED capsule when they need an extended runway — that pairing gives you the fast-onset layer plus the long-tail layer without double-stacking the same ingredients at dangerous levels. Do not exceed 2 pouches in 24 hours. Kanna + Sabroxy + methylliberine is already pushing on monoamine signaling, and stacking pouches invites serotonergic side effects.
    How should I dose Hypnos for sleep?+
    Hypnos is a once-nightly capsule taken 30–45 minutes before target sleep time. Loadings are oriented around kavain as the primary GABAergic driver, not melatonin — the melatonin is intentionally low-dose (physiologic, not pharmacologic). Per-serving: Kavain 400 mg (isolated kavalactone, not full-spectrum kava root), Oleamide 200 mg, Scutellaria baicalensis extract 200 mg (standardized to baicalin), Apigenin 100 mg, Tetrahydromagnolol 50 mg, Melatonin 2 mg. Onset is typically 30–60 minutes. Duration is oriented toward sleep maintenance (4–6 hours of subjective sedation) rather than aggressive knock-down. Important note: Hypnos uses isolated kavain, not traditional aqueous kava extract. Hepatotoxicity cases associated with kava products have predominantly involved ethanolic or acetonic extracts containing pipermethystine and flavokavins; purified kavain likely has a different risk profile but the research is not yet definitive. Do not combine Hypnos with alcohol, benzodiazepines, opioids, phenibut (INHBT), or other significant CNS depressants. Do not use if you have known hepatic impairment. Cycle: most users run Hypnos 3–5 nights per week rather than every night to preserve responsiveness and minimize tolerance at the GABA-A site.
    What is the INHBT (Phenibut) dosing protocol and cycle?+
    INHBT is a pre-social or pre-anxiolytic-situation capsule with strict cycling requirements. The loading is designed around phenibut 800 mg as the lead compound — which places it at the upper end of common research doses. Do not double-dose. Per-serving: Phenibut (β-phenyl-GABA) 800 mg, L-Tyrosine 500 mg, 2-aminoisoheptane (DMHA) 150 mg, saffron 15 mg, Huperzine A 400 mcg. Dosing protocol: 1 capsule taken 3–4 hours before the target situation (phenibut onset is slow — peak plasma at ~3 hours). Duration of subjective effect runs 8–15 hours depending on individual pharmacokinetics. **Cycle discipline is non-negotiable.** Phenibut has documented GABA-B receptor tolerance and a severe withdrawal syndrome when used more than 2–3 days consecutively or more than 2x per week. The Adera recommendation: maximum 1 capsule per week, no consecutive days, minimum 7-day washout. Users who report "phenibut works until it doesn't" are almost always exceeding this frequency and running into tolerance + withdrawal. Do not combine INHBT with: alcohol, benzodiazepines, opioids, Hypnos (kavain), baclofen, or GHB analogs. The GABA-B synergy is dangerous at supratherapeutic combined exposure. Regulatory: Phenibut is restricted in Australia, France, Italy, Hungary, Lithuania, and parts of the Middle East. Adera cannot ship INHBT to restricted jurisdictions. Check your local law.
    What is the Selank nasal spray dosing protocol?+
    Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) administered intranasally. Oral administration is largely ineffective — peptide bonds don't survive gastric hydrolysis. Intranasal delivery bypasses that and allows direct uptake through the olfactory mucosa. Common research dose: 1–3 sprays per nostril (typical concentrations 250–500 mcg per spray, batch-dependent) 1–2 times daily. Total daily research exposure commonly ranges 400–900 mcg. Onset is rapid (15–30 minutes) with a relatively short acute window (2–4 hours of subjective effect) but evidence for downstream effects persisting beyond the acute phase. Storage: refrigerate after opening. Peptide stability in solution drops meaningfully at room temperature over weeks — refrigerated, typical shelf life runs 4–6 weeks post-opening. Research-use framing: Selank is not a scheduled substance in the US but is not FDA-approved for any indication. Adera sells it labeled research-use only. See [the BodyHackGuide Selank compound page](/compound/selank) for mechanism briefs (tuftsin derivative, putative BDNF/NGF modulation, GABAergic downstream effects). Common stacking mistake: combining Selank spray with benzodiazepines expecting additive anxiolysis. The current literature doesn't clearly support additivity and the downstream GABAergic modulation is not well-characterized — keep stacks simple until more is known.
    How does the BDNF nasal spray dose?+
    The BDNF Spray is a BDNF-mimetic nasal-delivered formulation. "BDNF mimetic" means the active compound is a small molecule that activates the TrkB receptor downstream of where BDNF itself would act — not BDNF protein (which is too large and fragile to survive intranasal delivery as a therapeutic). Common research dose: 1–2 sprays per nostril once daily. Onset is not subjectively obvious in the way a stimulant is — the effects are structural (downstream neurotrophic signaling) rather than acute. Most research frames benefit over weeks, not hours. Storage: refrigerate after opening. Like other peptide/small-molecule intranasal formulations, stability drops at room temperature over weeks. Stacking: BDNF spray pairs mechanistically well with Selank spray (heptapeptide → putative BDNF/NGF modulation downstream) but there's no strong literature on combined use. Keep stacks simple initially. Do not combine with SSRIs without understanding that SSRIs also upregulate BDNF signaling — the additivity is unknown. Research-use only. Not FDA-approved. Not a replacement for any diagnosed condition's standard-of-care therapy. See [the BodyHackGuide cognitive-enhancement pages](/best-nootropics-for-focus) for context on where TrkB-active compounds sit in the research landscape.
    How does Adera test product purity?+
    Every batch goes through third-party analytical testing using two complementary techniques: **NMR (nuclear magnetic resonance)** confirms the structural identity of the compound — it tells you whether what's in the bottle is actually, say, kavain and not some cheaper substitute with similar appearance. **HPLC (high-performance liquid chromatography)** quantifies purity — how much of the compound is present by mass percentage, and what impurities (if any) are detectable. Testing is performed on the **finished formulation** (the actual product you receive), not just the raw ingredient before blending. This matters because manufacturing steps can introduce contaminants and ingredient degradation that raw-material COAs don't capture. Certificates of analysis are available by request — contact the Adera support team via their site contact form with your order number and the product you want the COA for. Turnaround is usually 24–48 hours.
    How fast does Adera ship and where?+
    **US orders:** ship within 48 hours of payment confirmation. Transit time depends on your location — West Coast to East Coast typically 3–5 business days with standard shipping. Adera uses USPS Priority and UPS Ground depending on package size. **International:** available for most products but several are restricted. Phenibut (INHBT) cannot ship to Australia, France, Italy, Hungary, Lithuania, or parts of the Middle East. Kava-derived products (Hypnos uses isolated kavain) have their own jurisdiction patchwork — Germany lifted its kava ban in 2015 but other EU countries still restrict. Check your local law before ordering; Adera will refund restricted-jurisdiction orders but you lose the international shipping fee. **Tracking:** provided via email once the order leaves the warehouse. For peptide sprays (Selank, BDNF), shipping is prioritized with cold-pack inserts for summer transit — this is done automatically, no action needed on your side. **Customs:** for international orders, you are responsible for any customs duties or import fees in your country. Adera does not cover those.
    How should I store each product type?+
    **Capsules (BLITZED, Hypnos, INHBT):** cool, dry place away from direct sunlight. Sealed container. Shelf life is typically 18–24 months from the batch date (check the label). Refrigeration is optional but can extend shelf life — no harm done. **Pouches (AMP Pouches):** room temperature, away from moisture. Do not refrigerate — condensation will degrade the pouch structure. Sealed container once opened. **Nasal sprays (Selank, BDNF):** refrigerate after opening. Peptide and peptide-mimetic stability in aqueous solution drops meaningfully at room temperature over weeks — refrigerated, typical shelf life runs 4–6 weeks post-opening. Before opening, cool, dry storage is fine but refrigeration is better. Do not freeze (freeze-thaw cycles damage peptide structure). **All products:** keep out of reach of children. The front-loaded stimulant stacks (BLITZED, AMP, INHBT) in particular are not formulated for pediatric exposure at any dose.
    Which products are legally restricted in my country?+
    Adera ships from the US and can deliver to most global jurisdictions, but specific products are regulated locally: **Phenibut (INHBT):** Unscheduled in the US federally. Banned or restricted in Australia, France, Italy, Hungary, Lithuania, Kazakhstan, Russia's consumer market, and parts of the Middle East. Some jurisdictions (e.g. UK) do not have explicit scheduling but customs occasionally seize shipments under general research-chemical provisions. **Kavain (Hypnos):** US federally unscheduled. The EU had a patchwork pattern after the 2002 kava hepatotoxicity scare — Germany re-permitted kava in 2015, but other EU states retained restrictions. Australia restricts commercial kava. Some other jurisdictions (UAE, Oman) prohibit it. **Selank and BDNF sprays:** US unscheduled. Most countries have no specific scheduling but peptide research compounds face border-control scrutiny in some jurisdictions (notably Australia, New Zealand, Canada). **The other capsule stacks (BLITZED, AMP Pouches):** the ingredients are generally unscheduled worldwide. DMHA (2-aminoisoheptane) is the only borderline-regulated ingredient; it remains unscheduled federally in the US but some state-level rules and several European countries have moved on it. Adera publishes a restricted-jurisdiction checklist at checkout. You are responsible for compliance with your local law — Adera will not ship knowingly to restricted jurisdictions but cannot independently verify every address against every country's rules.
    Is there a current discount code?+
    Coupon and discount strategy is managed directly by Adera — check the vendor's homepage and email list for current offers. This BodyHackGuide vendor page is an informational hub; it does not gate pricing or apply any BHG-specific coupon by default (the BODYHACKGUIDE code that appeared previously was removed). For the most accurate current pricing and any active promotions, go directly to the Adera product pages linked on this hub. Sign up for the Adera newsletter on their site if you want promotional notifications — Adera occasionally runs small-percentage codes around new product launches.

    Shipping

    Speed: 48 hour fulfillment

    Standard shipping to US addresses ships within 48 hours of order. International shipping available but restricted by local regulations — check your jurisdiction before ordering compounds like Phenibut.

    Compliance & Research Use

    All Adera products are sold for research use only and are not labeled, formulated, or intended for treatment, cure, mitigation, or prevention of any disease. Nothing on the product pages constitutes medical advice.

    COAs are available by request for any in-stock product. Contact the Adera support team via the contact form with your order number. Third-party test results include NMR and HPLC verification at batch level.

    Orders require the purchaser be 18 years of age or older. Adera does not ship to minors.

    Several Adera products face regulatory patchwork in the EU and UK. Phenibut (INHBT) cannot ship to France, Italy, Hungary, or Lithuania. Kavain-containing products (Hypnos) have jurisdiction-specific restrictions across the EU (Germany lifted its kava ban in 2015 but other states retained restrictions). Peptide sprays (Selank, BDNF) typically ship to EU/UK addresses but face customs-level scrutiny. Adera's checkout will block known-restricted destinations, but the customer is responsible for confirming local law.

    Due to research-chemical regulatory requirements, Adera cannot accept returns of opened products. Unopened products can be returned within 14 days of receipt for a refund minus shipping. Defective or mis-shipped products are replaced at Adera's expense — contact support with photos and your order number within 48 hours of receipt. Refunds are issued to the original payment method within 5–7 business days of return receipt.

    Peptide-based products (Selank Spray, BDNF Spray) are priced per batch rather than at a fixed catalog price because the cost of research-grade peptide raw material moves meaningfully between lots. Rather than publishing a stale fixed price that may not match current batch cost, Adera lists these two products with a "contact for current pricing" workflow. For current pricing, either: (1) click through to the Adera store and check the live product page, or (2) contact Adera support with the product name and they'll quote the current per-bottle price plus shipping. Quotes are typically returned within 24 hours during business days. The capsule and pouch products (BLITZED, AMP Pouches, Hypnos, INHBT) have stable pricing because the ingredient cost structure on those is dominated by standardized herbal extracts (Sabroxy, Rhodiola, kavain isolate) rather than batch-sensitive peptide material.

    Use With BodyHackGuide Tools

    Ready to shop Adera?

    Pharmaceutical-grade nasal sprays, sublingual pouches & nootropic capsules — third-party NMR + HPLC tested

    Visit Adera

    BodyHackGuide may earn a commission from qualifying purchases made through links on this page. This does not affect editorial content or vendor trust scoring.